Patents by Inventor Stanley G. Rockson

Stanley G. Rockson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LTB4 inhibition to prevent and treat human lymphedema
    Patent number: 10500178
    Abstract: Provided are therapeutic methods for treating a patient with lymphedema, or prophylactically treating an individual susceptible to lymphedema, by inhibiting synthesis activity of leukotriene B4.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: December 10, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Stanley G. Rockson, Mark R. Nicolls, Wen A. Tian, Xinguo Jiang, Jeanna Kim
  • LTB4 INHIBITION TO PREVENT AND TREAT HUMAN LYMPHEDEMA
    Publication number: 20180193296
    Abstract: Provided are therapeutic methods for treating a patient with lymphedema, or prophylactically treating an individual susceptible to lymphedema, by inhibiting synthesis activity of leukotriene B4.
    Type: Application
    Filed: March 11, 2016
    Publication date: July 12, 2018
    Inventors: Stanley G. Rockson, Mark R. Nicolls, Wen A. Tian, Xinguo Jiang, Jeanna Kim
  • Method for the treatment of acquired lymphedema
    Patent number: 8965708
    Abstract: The present invention identifies genes whose gene products are differentially expressed in lymphedema tissues, particularly cutaneous tissue involved in whole organ response to lymphedema. The invention provides methods for diagnosing or assessing an individual's susceptibility to lymphedema. Also provided are therapeutic methods for treating a patient or methods for prophylactically treating an individual susceptible to lymphedema. Additionally, the invention describes screening methods for identifying agents that can be administered to treat individuals that have or at risk of developing lymphedema.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: February 24, 2015
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Raymond Tabibiazar, Stanley G. Rockson
  • Lymphedema associated genes and model
    Publication number: 20120076731
    Abstract: The present invention identifies genes whose gene products are differentially expressed in lymphedema tissues, particularly cutaneous tissue involved in whole organ response to lymphedema. The invention provides methods for diagnosing or assessing an individual's susceptibility to lymphedema. Also provided are therapeutic methods for treating a patient or methods for prophylactically treating an individual susceptible to lymphedema. Additionally, the invention describes screening methods for identifying agents that can be administered to treat individuals that have or at risk of developing lymphedema.
    Type: Application
    Filed: July 28, 2011
    Publication date: March 29, 2012
    Inventors: Raymond Tabibiazar, Stanley G. Rockson